Ciprofloxacin Hydrochloride Ophthalmic Solution is a sterile topical antibiotic solution for the treatment of corneal ulcers, conjunctivitis, blepharitis, keratitis, and other susceptible bacterial infections of the eye in cats, dogs, and horses. The active ingredient, Ciprofloxacin, is a fluoroquinolone antibacterial that is active against a broad spectrum of gram-positive and gram-negative ocular pathogens.
Ciprofloxacin Hydrochloride Ophthalmic Solution is used to treat conjunctivitis as well as many other susceptible bacterial infections of the eye, including gram-positive and gram-negative pathogens that cause eye infection. It works by stopping bacteria from making DNA. This kills the bacteria and stops the infection.
Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
*Efficacy for this organism was studied in fewer than 10 infections.
Tip: Do not touch the dropper to any surface, including the surface of your pet's eye.
|Dosage for Cats, Dogs & Horses|
|All weights||Use as prescribed by your veterinarian.|
Safe use in pregnant pets or pets intended for breeding has not been proven. If your pet's condition worsens or does not improve, stop product administration and consult your veterinarian. Ciprofloxacin Hydrochloride Ophthalmic Solution 0.3% is for topical ophthalmic use only. It is not for injection into the eye. Sensitivity to topically applied aminoglycosides may occur in some pets. If your pet has a reaction to Ciprofloxacin Hydrochloride Ophthalmic Solution 0.3%, discontinue use and consult your veterinarian.
Store at 36°-77°F (2°-25°C).
A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.
Not for Injection into the Eye.
Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated.
Remove contact lenses before using.
The usual recommended dosage for corneal ulcers is two (2) drops into the affected eye every 15 minutes for the first six hours and then two (2) drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth days, place two drops in the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelialization (wound healing) has not occurred.
The usual recommended dosage for bacterial conjunctivitis is 1-2 drops instilled into the conjunctival sac(s) every 2 hours while awake for two days and 1-2 drops every 4 hours while awake for the next 5 days.